SCIENTIFIC BACKGROUND

FXN

Scientific Background

Friedreich ataxia (FRDA1) is the most common autosomal recessive inherited ataxia with a prevalence of approximately 1:20,000 (in Southwestern Europe) to 1:250,000 (in Northern and Eastern Europe). First symptoms usually appear before the age of 20. The main symptoms include progressive gait ataxia, dysarthria, nystagmus, hollow high-arched foot feet (Friedreich's foot), predominantly sensory neuropathy with abnormalities in electrophysiology, lack of muscular reflexes, and pyramidal path tract signs. Initially, hypertrophic cardiomyopathy is often seen, later dilated cardiomyopathy is also observed. In the course of the disease initially hypertrophic, later also dilated cardiomyopathy is often observed. Not infrequently, visual acuity is impaired by optic atrophy, while hearing impairment is observed in less than 10%. Cognitive abilities are usually not impaired, and about 30% of those affected develop diabetes mellitus. Neuropathological findings include evidence of degeneration of the dorsal pathways, the spinocerebellar tract and the sensory neurons of the dorsal root cells. Death usually occurs in the 4th decade of life, often as a result of cardiomyopathy or impaired brain stem functions.

 

The disease is caused by a GAA triplet repeat expansion in intron 1 of the FXN gene. Normal persons have about 7-33 GAA repeats. In healthy premutation carriers, 34-65 uninterrupted GAA triplets can be detected, which may be extended when passed on to the next generation. Patients have 66 to about 1,700 repeats. In more than 95-98% of cases the disease is caused by two alleles with the GAA triplet repeat expansion, while in about 2-3% the cause is expansion on one allele and a point mutation, more rarely a deletion, on the other FXN allele. GAA expansion reduces the expression of frataxin, a protein involved in mitochondrial iron homeostasis.

 

References

Cook et al. 2017, Br Med Bull.; 124:19 / Bürk, 2017, Cerebellum Ataxias; 4: 4 / Schulz et al. 2009, Nat Rev Neurol 5:222 / Pandolfo et al. 2009, J Neurol 256:Suppl 1 / Wilson 2006, Semin Pediatr Neurol 13:166 / Delatycki et al. 2000, J Med Genet 37:1 / Montermini et al. 1997, Hum Mol Genet 6:1261 / Dürr et al. 1996, New Eng J Med 335:1169 / Campuzano et al. 1996, Science 271:1423

GENES

FXN

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Background information on in vitro diagnostic services Laboratory-based testing methods and medical devices play a critical role in diagnosis and ...

Read more

Traditional DNA tests may overlook 10% of classic in Familial Adenomatous Polyposis (FAP) cases. By integrating RNA sequencing, researchers unveiled ...

Read more

Overview In January 2024, the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) published new recommendation...

Read more

Endometriosis is a chronic gynecological condition that affects 1 in 10 women of reproductive age worldwide [1]. It can manifest with the first menst...

Read more

Rare Disease Day is a global awareness day held annually to raise awareness of all rare diseases. It was first celebrated in 2008, on the rarest day ...

Read more

Cancer is a group of genetic diseases that can develop almost anywhere in the body. Many people in the world are affected by cancer every year. Follo...

Read more

Aiming to evaluate the role of chromosomal aneuploidy in pregnancy loss, a 2023 study 35 years in the making evaluated the genomic landscape of first...

Read more

Cancer is a complex genetic disease that affects millions of people in the world. It is one of the leading causes of death worldwide, with about ten ...

Read more

Researchers created a detailed map of the placenta during labor. By studying how maternal and fetal cells communicate, they discovered signals in the...

Read more

A recent paper published in Nature Medicine (1) aimed to identify genes and genomic biomarkers which can better predict outcomes and personalized the...

Read more